Frost & Sullivan: Cardiac Troponin Diagnostics Market Growth Boosted by High-sensitivity Point-of-care Testing
November 30, 2022
November 30, 2022
SAN ANTONIO, Texas, Nov. 30 (TNSres) - Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:
* * *
The rise in emergency department visits due to cardiac complaints drives the demand for cTn biomarkers
* * *
The global demand for cardiac troponin (cTn) diagnostics biomarkers is increasing as more patients with card . . .
* * *
The rise in emergency department visits due to cardiac complaints drives the demand for cTn biomarkers
* * *
The global demand for cardiac troponin (cTn) diagnostics biomarkers is increasing as more patients with card . . .